Surveillance of adverse events following immunization: 10 years' experience in Oman
AbstractA descriptive record-based review of adverse events following immunization [AEFI] was carried out in Oman using the national database for the period 1996-2005. A total of 790 adverse event reports were received with an annual rate during the review period of 33.7 per 100000 population or 10.8 per 100000 doses administered. There were no reported deaths. The most frequently reported AEFI were BCG adenitis [69.7 per 100000 doses] and local reactions [3.6 per 100000 doses respectively]. The statistically significant higher rates among males, in children aged > 2 years and in some sparsely populated regions of Oman need further research. AEFI rates in Oman were similar or below the international averages
Al Awaidy, S., Bawikar, S., Prakash, K.P., Al Rawahi, B. & Mohammed, A.J. (2010). Surveillance of adverse events following immunization: 10 years' experience in Oman. http://www.who.int/iris/handle/10665/117901
EMHJ - Eastern Mediterranean Health Journal, 16 (5), 474-480, 2010
MetadataShow full item record
Showing items related by title and MeSH subject.
Address by Dr Ala Alwan Regional Director WHO Eastern Mediterranean Region to the African Ministerial Conference Addis Ababa, Ethiopia, 24-25 February 2016 World Health Organization, Regional Office for the Eastern Mediterranean (2016-02-24)